AI for Drug Discovery
Insilico Medicine, founded by Alex Zhavoronkov in Hong Kong, utilizes AI to accelerate drug discovery and development. Their technology helps identify potential drug candidates faster and more cost-effectively. Insilico Medicine recently secured $60 million in Series C funding.